Naphthol AS-BI N-acetyl-b-D-glucosaminide
CAS: 3395-37-7
Rif. 3D-EN06141
25mg | 175,00 € | ||
50mg | 237,00 € | ||
100mg | 371,00 € | ||
250mg | 660,00 € | ||
500mg | 943,00 € |
Informazioni sul prodotto
- 2-Naphth-o-anisidide, 3-[(2-acetamido-2-deoxy-β-<span class="text-smallcaps">D</span>-glucopyranosyl)oxy]-7-bromo-
- 2-Naphthalenecarboxamide, 3-[[2-(acetylamino)-2-deoxy-β-<span class="text-smallcaps">D</span>-glucopyranosyl]oxy]-7-bromo-N-(2-methoxyphenyl)-
- 3-[(2S,3R,4R,5S,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-7-bromo-N-(2-methoxyphenyl)naphthalene-2-carboxamide
- 3-[[2-(Acetylamino)-2-deoxy-β-<span class="text-smallcaps">D</span>-glucopyranosyl]oxy]-7-bromo-N-(2-methoxyphenyl)-2-naphthalenecarboxamide
- Glucopyranoside, 6-bromo-3-[(o-methoxyphenyl)carbamoyl]-2-naphthyl 2-acetamido-2-deoxy-+, β-<span class="text-smallcaps">D</span>-
Naphthol AS-BI N-acetyl-b-D-glucosaminide is an enzyme inhibitor that is used in the treatment of Gaucher's disease. The enzyme it inhibits is β-glucosidase, which breaks down glucocerebrosides in the lysosomes of cells. This drug prevents the breakdown of glucocerebrosides and increases their concentration in cells, which reduces the symptoms of Gaucher's disease. Naphthol AS-BI N-acetyl-b-D-glucosaminide has been shown to be effective against wild type and mutant forms of the enzyme. However, it does not work against patients who are homozygous for a mutation in exon 1 of the βglu gene that codes for βglu protein.
Proprietà chimiche
Richiesta tecnica su: 3D-EN06141 Naphthol AS-BI N-acetyl-b-D-glucosaminide
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.